Logo

Qiagen, Becton JV Sells Molecular Testing Tools to GlaxoSmithKline

Aug 06, 2002

NEW YORK, Aug. 6 - PreAnalytix, a Swiss-based joint venture between Qiagen and Becton Dickinson, has signed on GlaxoSmithKline as a new customer for its molecular-testing tools, PreAnalytix said yesterday.

The company's first product, the PaxGene Blood RNA system, is designed to help gene analysis of blood samples. It was launched in April 2001.

 

PreAnalytix, based in Hombrechtikon, is privately owned.

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.